Compare ZLAB & MAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | MAN |
|---|---|---|
| Founded | 2013 | 1948 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2017 | 1988 |
| Metric | ZLAB | MAN |
|---|---|---|
| Price | $17.92 | $36.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 6 |
| Target Price | ★ $51.52 | $39.67 |
| AVG Volume (30 Days) | 795.4K | ★ 1.3M |
| Earning Date | 02-26-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 3.93% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $441,629,000.00 | ★ $17,957,100,000.00 |
| Revenue This Year | $26.16 | $4.14 |
| Revenue Next Year | $30.62 | $3.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 24.14 | 0.58 |
| 52 Week Low | $15.96 | $26.14 |
| 52 Week High | $44.34 | $63.35 |
| Indicator | ZLAB | MAN |
|---|---|---|
| Relative Strength Index (RSI) | 45.10 | 66.58 |
| Support Level | $15.96 | $34.09 |
| Resistance Level | $17.86 | $37.59 |
| Average True Range (ATR) | 0.62 | 1.78 |
| MACD | -0.03 | 0.62 |
| Stochastic Oscillator | 44.03 | 91.29 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that include Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives the maximum of the company's revenue. The company derives maximum geographical revenue from the Southern European region.